Literature DB >> 10818608

DNA release by line-1 (L1) retrotransposon. Could it be possible?

G Alves1, M T Kawamura, P Nascimento, C Maciel, J A Oliveira, A Teixeira, M da G Carvalho.   

Abstract

We have verified the presence of line-1 retrotransposon (L1) in plasma DNA in 15/17 brain tumor (glioma) patients and in 6/6 healthy people by applying PCR amplification of part of the L1 5' end. The same samples were separately amplified for K-ras. Results suggested that L1 sequences are circulating throughout the body. We hypothesized the participation of transposable elements such as L1 in a putative DNA release mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818608     DOI: 10.1111/j.1749-6632.2000.tb06602.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

1.  Bov-tA short interspersed nucleotide element sequences in circulating nucleic acids from sera of cattle with bovine spongiform encephalopathy (BSE) and sera of cattle exposed to BSE.

Authors:  Ekkehard Schütz; Howard B Urnovitz; Leonid Iakoubov; Walter Schulz-Schaeffer; Wilhelm Wemheuer; Bertram Brenig
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

2.  Transcriptional regulation of the human LINE-1 retrotransposon L1.2B.

Authors:  C Steinhoff; W A Schulz
Journal:  Mol Genet Genomics       Date:  2003-10-07       Impact factor: 3.291

3.  L1 retrotransposons in human cancers.

Authors:  Wolfgang A Schulz
Journal:  J Biomed Biotechnol       Date:  2006

Review 4.  The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.

Authors:  Yahya I Elshimali; Husseina Khaddour; Marianna Sarkissyan; Yanyuan Wu; Jaydutt V Vadgama
Journal:  Int J Mol Sci       Date:  2013-09-13       Impact factor: 5.923

5.  Epigenetics and autoimmune diseases: the X chromosome-nucleolus nexus.

Authors:  Wesley H Brooks; Yves Renaudineau
Journal:  Front Genet       Date:  2015-02-16       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.